Furthermore, pharmacological or genetic inhibition of mTOR activity is shown to improve autophagic clearance, reverse DA neuronal damage and alleviate PD symptoms (Jahrling and Laberge, 2015; Martini-Stoica et al., 2016). This evidence concerns the gene MTOR and Parkinson disease.